Table I.
Association of miR-433 expression with clinicopathological data and outcome of colorectal cancer patients (n=85).
miR-433 expression | ||||
---|---|---|---|---|
Parameters | n | High | Low | P-valuea |
Sex, n | 0.730 | |||
Male | 47 | 19 | 28 | |
Female | 38 | 14 | 24 | |
Age (years) | 0.130 | |||
<65 | 37 | 11 | 26 | |
≥65 | 48 | 22 | 26 | |
UICC stage, n | <0.001 | |||
I | 15 | 12 | 3 | |
II | 31 | 12 | 19 | |
III | 39 | 9 | 30 | |
Lymph node metastasis, n | 0.700 | |||
+ | 39 | 16 | 23 | |
− | 46 | 17 | 29 | |
Tumor differentiation, n | 0.730 | |||
Well | 20 | 9 | 11 | |
Medium | 41 | 16 | 25 | |
Poor | 24 | 8 | 16 | |
Tumor size, n (cm) | 0.220 | |||
<5 | 45 | 20 | 25 | |
≥5 | 40 | 13 | 27 | |
Early relapse, n | <0.001 | |||
Yes | 40 | 4 | 36 | |
No | 45 | 29 | 16 |
χ2 test. miRNA, microRNA; UICC, Union for International Cancer Control.